XML 64 R52.htm IDEA: XBRL DOCUMENT v3.19.1
Pro Forma Financial Statements (Details 1) - USD ($)
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Revenues
Cost of revenues
Gross profit
Operating expenses    
Selling, general and administrative expenses 695,148 811,685
Research and development expenses 669,668 3,171,665
Stock based compensation 28,800 155,400
Total operating expenses 1,393,616 4,138,750
Loss from operations (1,393,616) (4,138,750)
Other income (expense)    
Interest income 93 180
Interest Expense (155,930) (103,460)
Investment loss (549)
Total other income (expenses) (2,705,837) (103,280)
Loss before provision for income tax (4,099,453) (4,242,030)
Provision for income tax (benefit) 1,850 830
Net loss attributable to ABVC and subsidiaries $ (4,101,303) $ (4,242,860)
Net loss per share attributable to common stockholders    
Basic and diluted $ (0.02) $ (0.02)
Weighted average number of common shares outstanding    
Basic and diluted 213,884,105 213,321,921
Pro Forma Adjustment [Member]    
Revenues  
Cost of revenues  
Gross profit  
Operating expenses    
Selling, general and administrative expenses  
Research and development expenses  
Stock based compensation  
Total operating expenses  
Other income (expense)    
Interest income  
Interest Expense  
Rental income  
Impairment loss  
Investment loss  
Gain/Loss on foreign exchange changes  
Gain/Loss on investment in equity securities  
Other income (expense)  
Total other income (expenses)  
Loss before provision for income tax  
Provision for income tax (benefit)  
Net loss  
Net loss attributable to noncontrolling interests  
Net loss attributable to ABVC and subsidiaries  
Foreign currency translation adjustment  
Comprehensive Income (Loss)  
Net loss per share attributable to common stockholders    
Basic and diluted  
Weighted average number of common shares outstanding    
Basic and diluted  
Pro Forma Combined [Member]    
Revenues $ 517,153  
Cost of revenues 190,089  
Gross profit 327,064  
Operating expenses    
Selling, general and administrative expenses 2,258,040  
Research and development expenses 1,419,638  
Stock based compensation 28,800  
Total operating expenses 3,706,478  
Loss from operations (3,379,414)  
Other income (expense)    
Interest income 9,810  
Interest Expense (462,751)  
Rental income 11,924  
Impairment loss (63,663)  
Investment loss (396,025)  
Gain/Loss on foreign exchange changes 7,307  
Gain/Loss on investment in equity securities (2,741,914)  
Other income (expense) (4,524)  
Total other income (expenses) (3,639,836)  
Loss before provision for income tax (7,019,250)  
Provision for income tax (benefit) (364,297)  
Net loss (6,654,953)  
Net loss attributable to noncontrolling interests 489,151  
Net loss attributable to ABVC and subsidiaries (7,144,104)  
Foreign currency translation adjustment 86,786  
Comprehensive Income (Loss) $ (7,230,890)  
Net loss per share attributable to common stockholders    
Basic and diluted $ (0.03)  
Weighted average number of common shares outstanding    
Basic and diluted 214,156,988  
ABVC [Member]    
Revenues  
Cost of revenues  
Gross profit  
Operating expenses    
Selling, general and administrative expenses 695,148  
Research and development expenses 669,668  
Stock based compensation 28,800  
Total operating expenses 1,393,616  
Loss from operations (1,393,616)  
Other income (expense)    
Interest income 93  
Interest Expense (155,930)  
Rental income  
Impairment loss  
Investment loss (549)  
Gain/Loss on foreign exchange changes  
Gain/Loss on investment in equity securities (2,549,451)  
Other income (expense)  
Total other income (expenses) (2,705,837)  
Loss before provision for income tax (4,099,453)  
Provision for income tax (benefit) 1,850  
Net loss (4,101,303)  
Net loss attributable to noncontrolling interests  
Net loss attributable to ABVC and subsidiaries (4,101,303)  
Foreign currency translation adjustment  
Comprehensive Income (Loss) $ (4,101,303)  
Net loss per share attributable to common stockholders    
Basic and diluted $ (0.02)  
Weighted average number of common shares outstanding    
Basic and diluted 213,884,105  
BioKey [Member]    
Revenues $ 510,197  
Cost of revenues 4,809  
Gross profit 505,388  
Operating expenses    
Selling, general and administrative expenses 669,322  
Research and development expenses 430,917  
Stock based compensation  
Total operating expenses 1,100,239  
Loss from operations (594,851)  
Other income (expense)    
Interest income 4,598  
Interest Expense  
Rental income  
Impairment loss  
Investment loss  
Gain/Loss on foreign exchange changes  
Gain/Loss on investment in equity securities  
Other income (expense) 630  
Total other income (expenses) 5,228  
Loss before provision for income tax (589,623)  
Provision for income tax (benefit) 800  
Net loss (590,423)  
Net loss attributable to noncontrolling interests  
Net loss attributable to ABVC and subsidiaries (590,423)  
Foreign currency translation adjustment  
Comprehensive Income (Loss) $ (590,423)  
Net loss per share attributable to common stockholders    
Basic and diluted  
Weighted average number of common shares outstanding    
Basic and diluted  
BioLite [Member]    
Revenues $ 6,956  
Cost of revenues 185,280  
Gross profit (178,324)  
Operating expenses    
Selling, general and administrative expenses 893,570  
Research and development expenses 319,053  
Stock based compensation  
Total operating expenses 1,212,623  
Loss from operations (1,390,947)  
Other income (expense)    
Interest income 5,119  
Interest Expense (306,821)  
Rental income 11,924  
Impairment loss (63,663)  
Investment loss (395,476)  
Gain/Loss on foreign exchange changes 7,307  
Gain/Loss on investment in equity securities (192,463)  
Other income (expense) (5,154)  
Total other income (expenses) (939,227)  
Loss before provision for income tax (2,330,174)  
Provision for income tax (benefit) (366,947)  
Net loss (1,963,227)  
Net loss attributable to noncontrolling interests 489,151  
Net loss attributable to ABVC and subsidiaries (1,474,067)  
Foreign currency translation adjustment 86,786  
Comprehensive Income (Loss) $ (1,560,862)  
Net loss per share attributable to common stockholders    
Basic and diluted  
Weighted average number of common shares outstanding    
Basic and diluted